Stock SUVENPHAR SUVEN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Suven Pharmaceuticals Limited

Equities

SUVENPHAR

INE03QK01018

Pharmaceuticals

End-of-day quote NSE India S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
660.4 INR +1.47% Intraday chart for Suven Pharmaceuticals Limited +3.61% -8.63%
Mar. 27 Suven Pharmaceuticals Limited Announces Shifting of Registered Office CI
Mar. 05 Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call

Business Summary

Suven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

Number of employees: 1,193

Sales per Business

INR in Million2022Weight2023Weight Delta
Manufacturing (CRAMS)
100.0 %
13,202 100.0 % 13,403 100.0 % +1.52%

Sales per region

INR in Million2022Weight2023Weight Delta
Europe
86.7 %
11,048 83.7 % 11,618 86.7 % +5.16%
United States
6.2 %
585 4.4 % 834 6.2 % +42.47%
Rest of the World
4.5 %
1,126 8.5 % 600 4.5 % -46.70%
India
2.6 %
443 3.4 % 352 2.6 % -20.64%

Managers

Managers TitleAgeSince
Sudhir Singh CEO
 Chief Executive Officer - 23-09-28
Himanshu Agarwal DFI
 Director of Finance/CFO 30 Dec. 31
V. S. N. Murthy Murthy CTO
 Chief Tech/Sci/R&D Officer - -
Hanumantha Rao Kokkonda CMP
 Compliance Officer - -
V. V. N. K. V. Prasada Raju BRD
 Director/Board Member - 23-09-28
Brian Shaughnessy PRN
 Corporate Officer/Principal - 23-09-30
Subba Raju Komaravolu PRN
 Corporate Officer/Principal - 23-09-28
Kameshwar Rao Chrukuri PRN
 Corporate Officer/Principal - -
Veera Reddy Arava PRN
 Corporate Officer/Principal - -
C. Rajendiran PRN
 Corporate Officer/Principal 63 -

Members of the board

Members of the board TitleAgeSince
Kumarapuram G. Ananthakrishnan BRD
 Director/Board Member 67 23-09-28
Shweta Jalan BRD
 Director/Board Member 48 Nov. 08
Udhyavara Bhadya Pravin Rao BRD
 Director/Board Member 62 Nov. 08
Vinod Rao BRD
 Director/Board Member 61 23-09-28
Annaswamy Vaidheesh CHM
 Chairman 64 23-09-28
V. V. N. K. V. Prasada Raju BRD
 Director/Board Member - 23-09-28
Matangi Gowrishankar BRD
 Director/Board Member 66 23-09-28
Pankaj Patwari BRD
 Director/Board Member - 23-09-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 254,564,956 95,412,871 ( 37.48 %) 0 37.48 %

Shareholders

NameEquities%Valuation
Jasti Family
60.00 %
152,730,000 60.00 % 1 239 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
5.795 %
14,753,193 5.795 % 120 M ₹
DSP Asset Managers Pvt. Ltd.
4.778 %
12,163,643 4.778 % 99 M ₹
Amansa Holdings Pvt Ltd.
2.563 %
6,525,733 2.563 % 53 M ₹
Rambabu Chirumamila
2.229 %
5,675,166 2.229 % 46 M ₹
HSBC Asset Management (India) Pvt Ltd.
1.568 %
3,990,865 1.568 % 32 M ₹
Alpha Alternatives Msar LLP
1.092 %
2,781,000 1.092 % 23 M ₹
Tata Asset Management Ltd.
1.037 %
2,639,442 1.037 % 21 M ₹
Canara Robeco Asset Management Co. Ltd.
0.6584 %
1,675,983 0.6584 % 14 M ₹
SBI Life Insurance Co. Ltd. (Investment Portfolio)
0.6071 %
1,545,427 0.6071 % 13 M ₹

Company contact information

Suven Pharmaceuticals Ltd.

Door No. 8-2-334, 3rd Floor SDE Serene Chambers, Road No.5

500034, Hyderabad

+91 40 2354 9414

http://www.suvenpharm.com
address Suven Pharmaceuticals Limited(SUVENPHAR)

Group companies

NameCategory and Sector
Casper Pharma Pvt Ltd.
Logo Casper Pharma Pvt Ltd.

Casper Pharma Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Suven Pharmaceuticals Ltd., Casper Pharma Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hyderabad, India. The company was founded in 2016. Casper Pharma was acquired by Suven Pharmaceuticals Ltd. on June 30, 2022 for $20.75 million.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Suven Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
660.4 INR
Average target price
685.5 INR
Spread / Average Target
+3.79%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SUVEN PHARMACEUTICALS LIMITED Stock Suven Pharmaceuticals Limited
-8.63% 1.99B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.77% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.29% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.54% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.45% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.73% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.79% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 196B
AMGEN INC. Stock Amgen Inc.
-4.51% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SUVENPHAR Stock
  4. Company Suven Pharmaceuticals Limited